Is Stressed Heart Morphology an Early Imaging Biomarker or Continuous Phenomenon in Advance Hypertension?

kardiyoloji-15-5-kitap-kapak

Nurettin YERALa

aHatay Training and Research Hospital, Clinic of Cardiology, Hatay, Türkiye

ABSTRACT
Changes that develop in the myocardium of the hypertensive left ventricle (LV) and lead to its remodeling provide structural and functional support for changes in cardiac function and electrical activity that adversely affect the clinical evolution of patients with hypertensive heart disease. Because LV remodeling is not uncommon in the early stages of hypertensive heart disease, Stress Heart Morphology (SHM) may be an early imaging biomarker in incompletely treated patients with no target organ damage. SHM may be an early and specific feature not only in the hypertensive heart, but also in acute and chronic stress-related conditions. Basal septal hypertrophy with LV hyperfunction under stress in both animal models and humans can be detected by new quantitative cardiac imaging modalities, and this represents an early adaptive phase of LV remodeling prior to maladaptation. New geometric and functional imaging findings in the adaptive phase of the hypertensive heart may be a common point of determination in stress-mediated cardiac conditions, termed SHM.
Keywords: Hypertension; stress, psychological

Referanslar

  1. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821- 48. [Crossref]  [PubMed]
  2. Laukkanen JA, Kurl S. Blood pressure responses during exercise testing-is up best for prognosis? Ann Med. 2011. [Crossref]  [PubMed]
  3. Lauer MS, Pashkow FJ, Harvey SA, Marwick TH, Thomas JD. Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease. J Am Coll Cardiol. 1995;26:1630-6. [Crossref]  [PubMed]
  4. Sharman JE, Hare JL, Thomas S, Davies JE, Leano R, Jenkins C, et al. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens. 2011;24(8):898- 903. [Crossref]  [PubMed]
  5. Yalçin F, Kucukler N, Cingolani O, Mbiyangandu B, Sorensen L, Abraham MR, et al. Evolution of ventricular hypertrophy and myocardial mechanics in physiologic and pathologic hypertrophy. J Appl Physiol (1985). 2019;126:354-62. [Crossref]  [PubMed]  [PMC]
  6. Lee PT, Dweck MR, Prasher S, Shah A, Huphries SE, Pennell DJ, et al. Left ventricular wall thickness and presence of asymetric hypertrophy ın healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging. 2013;6:262-7. [Crossref]  [PubMed]
  7. Nadruz W. Myocardial remodlin in hypertension (Review). J Hum Hypertension. 2015;29(1):1-6. [Crossref]  [PubMed]
  8. González A, Ravassa S, López B, Moreno MU, Beaumont J, San José G, et al. Myocardial remodeling in hypertension. Hypertension. 2018;72(3):549-58. [Crossref]  [PubMed]
  9. Schiattarella GG, Hill JA. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation. 2015;131:1435- 47. [Crossref]  [PubMed]  [PMC]
  10. Yalçin F, Yalçin H, Abraham MR, Abraham TP. Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging. Am J Cardiovasc Dis. 2021;11(5):628-34.
  11. Come PC, Bulkley BH, Goodman ZD, Hutchins GM, Pitt B, Fortuin NJ. Hypercontractile cardiac states simulating hypertrophic cardiomyopathy. Circulation. 1977;55:901-8. [Crossref]  [PubMed]
  12. Hinderliter AL, Light KC, Willis PW. Patients with borderline elevated blood pressure have enhanced left ventricular contractility. Am J Hypertens. 1995;8:1040-5. [Crossref]  [PubMed]
  13. Fatih Yalcin J. Stress-related cardiac diseases and stressed heart morphology. 5th International Conference on Clinical & Experimental Cardiology April 27-29, 2015 Philadelphia, USA.
  14. Yalçin F, Yalçin H, Küçükler N, et al. Basal septal hypertrophy as the early ımaging biomarker for adaptive phase of remodeling prior to heart failure. J Clin Med. 2021;11(1):75. [Crossref]  [PubMed]  [PMC]
  15. Vaduganathan M, Sattar N, Xu J, Butler J, Mahaffey KW, Neal B, et al. Stress cardiac biomarkers, cardiovascular and renal outcomes, and response to canagliflozin. J Am Coll Cardiol. 2022;79(5):432-44. [Crossref]  [PubMed]
  16. Yeral N, et al. Blockage of Angiotensın 2 receptor-1 effects not only on stress-ınduced myocardial Dynamics but on circulating cathecolamins in hypertensive patients. 22nd European meeting on hypertension and cardiovascular protection. London (UK), April 26-29, 2012.